Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients

Kristine A Frerichs; Patricia W C Bosman; Jeroen F van Velzen; Pieter L A Fraaij; Marion P G Koopmans; Guus F Rimmelzwaan; Inger S Nijhof; Andries C Bloem; Tuna Mutis; Sonja Zweegman; Niels W C J van de Donk

doi:10.3324/haematol.2019.231860

Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients

Kristine A Frerichs, Patricia W C Bosman, Jeroen F van Velzen, Pieter L A Fraaij, Marion P G Koopmans, Guus F Rimmelzwaan, Inger S Nijhof, Andries C Bloem, Tuna Mutis, Sonja Zweegman, Niels W C J van de Donk

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Article number	e302-e306
Pages (from-to)	E302-E306
Journal	Haematologica
Volume	105
Issue number	6
Early online date	26 Sep 2019
DOIs	https://doi.org/10.3324/haematol.2019.231860
Publication status	Published - 1 Jun 2020

Access to Document

10.3324/haematol.2019.231860

Cite this

Frerichs, K. A., Bosman, P. W. C., van Velzen, J. F., Fraaij, P. L. A., Koopmans, M. P. G., Rimmelzwaan, G. F., Nijhof, I. S., Bloem, A. C., Mutis, T., Zweegman, S., & van de Donk, N. W. C. J. (2020). Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients. Haematologica, 105(6), E302-E306. [e302-e306]. https://doi.org/10.3324/haematol.2019.231860

@article{25147fb1b10e4f6bbb450a88117dc390,

title = "Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients",

author = "Frerichs, {Kristine A} and Bosman, {Patricia W C} and {van Velzen}, {Jeroen F} and Fraaij, {Pieter L A} and Koopmans, {Marion P G} and Rimmelzwaan, {Guus F} and Nijhof, {Inger S} and Bloem, {Andries C} and Tuna Mutis and Sonja Zweegman and {van de Donk}, {Niels W C J}",

note = "Funding Information: 1Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam; 2University Medical Center, Laboratory of Translational Immunology, Utrecht and 3Erasmus Medical Center, Department of Viroscience, National Influenza Center, Rotterdam, the Netherlands. °Current address: University of Veterinary Medicine, Center for Emerging Infections and Zoonoses, Hannover, Germany Funding: the DARA/ATRA study was supported by research funding from Janssen Pharmaceuticals. Correspondence: Niels W.C.J. van de Donk n.vandedonk@amsterdamumc.nl doi:10.3324/haematol.2019.231860 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2020",

month = jun,

day = "1",

doi = "10.3324/haematol.2019.231860",

language = "English",

volume = "105",

pages = "E302--E306",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "6",

}

Frerichs, KA, Bosman, PWC, van Velzen, JF, Fraaij, PLA, Koopmans, MPG, Rimmelzwaan, GF, Nijhof, IS, Bloem, AC, Mutis, T , Zweegman, S & van de Donk, NWCJ 2020, 'Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients', Haematologica, vol. 105, no. 6, e302-e306, pp. E302-E306. https://doi.org/10.3324/haematol.2019.231860

Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients. / Frerichs, Kristine A; Bosman, Patricia W C; van Velzen, Jeroen F et al.

In: Haematologica, Vol. 105, No. 6, e302-e306, 01.06.2020, p. E302-E306.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients

AU - Frerichs, Kristine A

AU - Bosman, Patricia W C

AU - van Velzen, Jeroen F

AU - Fraaij, Pieter L A

AU - Koopmans, Marion P G

AU - Rimmelzwaan, Guus F

AU - Nijhof, Inger S

AU - Bloem, Andries C

AU - Mutis, Tuna

AU - Zweegman, Sonja

AU - van de Donk, Niels W C J

N1 - Funding Information: 1Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam; 2University Medical Center, Laboratory of Translational Immunology, Utrecht and 3Erasmus Medical Center, Department of Viroscience, National Influenza Center, Rotterdam, the Netherlands. °Current address: University of Veterinary Medicine, Center for Emerging Infections and Zoonoses, Hannover, Germany Funding: the DARA/ATRA study was supported by research funding from Janssen Pharmaceuticals. Correspondence: Niels W.C.J. van de Donk n.vandedonk@amsterdamumc.nl doi:10.3324/haematol.2019.231860 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/6/1

Y1 - 2020/6/1

UR - http://www.scopus.com/inward/record.url?scp=85085714907&partnerID=8YFLogxK

U2 - 10.3324/haematol.2019.231860

DO - 10.3324/haematol.2019.231860

M3 - Letter

C2 - 31558675

VL - 105

SP - E302-E306

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 6

M1 - e302-e306

ER -

Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients

Access to Document

Other files and links

Cite this